The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The following information was prepared in collaboration with the MDS Foundation.
As a patient with acute myeloid leukemia, you may be particularly susceptible to the effects of COVID-19; therefore, measures have been put in place to minimize the risk of you contracting the virus. Patients with acute myeloid leukemia who are not showing symptoms and not receiving treatment should discuss alternatives to clinic visits with their healthcare provider. Many questions can be answered by phone or via a telemedicine visit.
Patients who are on active treatments or receiving transfusions should continue to attend any scheduled appointments unless they are contacted by a member of their healthcare team and advised otherwise. It is a good idea for patients to contact their leukemia specialist prior to each scheduled appointment to see if the appointment is essential, and to possibly conduct the visit by phone or telemedicine. Sometimes it may also be possible to have routine lab tests drawn locally or at home to avoid travel.
It is essential that patients with ANY symptoms of cough, fever, diarrhea, loss of taste/smell, or chills, contact their healthcare provider (most cancer centers have hotlines, the numbers can be found on their websites) for instructions on how to proceed BEFORE coming into the hematology clinics. This ensures that you do not potentially expose other immunocompromised patients to the virus. If possible, wear a mask that covers both your nose and mouth when attending hospitals or clinics.
The following general recommendations were prepared by the Aplastic Anemia and MDS International Foundation.
Contact your leukemia specialist with any questions or specific concerns.
The coronaviruses are a large family of viruses, which may cause illness in animals or humans. COVID-19 is the disease caused by the most recently discovered coronavirus, which originated the current pandemic. Other coronaviruses are those causing the Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). Symptoms of COVID-19 may resemble flu as both can cause fever and cough, body aches, and fatigue. The symptoms of COVID-19 usually appear between two and 14 days after being exposed to the virus and vary between mild to severe. Some people can develop breathing difficulties caused by the virus.
COVID-19 can spread from person to person through small droplets when an infected person coughs or sneezes, which is why it is important to maintain social distancing and to wash your hands often and thoroughly.
It is important that you stay up to date with the latest information and guidelines from your country’s health authorities and other trusted sources, such as the World Health Organization (WHO).
Blood Cancer UK (guidance for patients with blood cancer – United Kingdom)
Centers for Disease Control and Prevention
National Health Service (United Kingdom)
Aplastic Anemia & MDS International Foundation (guidance for patients with bone marrow failure)
After reading this information, do you feel better informed about the recommendations regarding COVID-19 for patients with acute myeloid leukemia?